Blinded by the UV light: How the focus on transcription-coupled NER has distracted from understanding the mechanisms of Cockayne syndrome neurologic disease

DNA Repair

Volumn 12, Issue 8, 2013, Pages 656-671

  Brooks, P J ^a,b  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Aging; Calcification; Demyelination; Developmental disorders; Leukodystrophy; Neurodegeration; Rare disease; Vasculopathy

Indexed keywords

DNA; RNA POLYMERASE; RNA POLYMERASE II;

ARTICLE; COCKAYNE SYNDROME; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA DAMAGE; HUMAN; NONHUMAN; NUCLEIC ACID STRUCTURE, METABOLISM AND FUNCTION; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR; ULTRAVIOLET RADIATION;

AGING; CALCIFICATION; DEMYELINATION; DEVELOPMENTAL DISORDERS; LEUKODYSTROPHY; NEURODEGERATION; RARE DISEASE; VASCULOPATHY;

ANIMALS; COCKAYNE SYNDROME; DISEASE MODELS, ANIMAL; DNA DAMAGE; DNA REPAIR; DNA REPAIR-DEFICIENCY DISORDERS; HUMANS; MICE; OXIDATIVE STRESS; RNA POLYMERASE I; RNA POLYMERASE II; TRANSCRIPTION, GENETIC; ULTRAVIOLET RAYS; XERODERMA PIGMENTOSUM;

EID: 84880643675     PISSN: 15687864     EISSN: 15687856     Source Type: Journal    
DOI: 10.1016/j.dnarep.2013.04.018     Document Type: Article

References (166)

1. DiGiovanna J.J., Kraemer K.H. Shining a light on xeroderma pigmentosum. J. Invest. Dermatol. 2012, 132:785-796.
2. Friedberg E.C. Nucleotide excision repair of DNA: the very early history. DNA Repair (Amst.) 2011, 10:668-672.
3. Cleaver J.E. Defective repair replication of DNA in xeroderma pigmentosum. Nature 1968, 218:652-656.
4. Venema J., Mullenders L.H., Natarajan A.T., van Zeeland A.A., Mayne L.V. The genetic defect in Cockayne syndrome is associated with a defect in repair of UV-induced DNA damage in transcriptionally active DNA. Proc. Natl. Acad. Sci. U.S.A. 1990, 87:4707-4711.
5. van Hoffen A., Natarajan A.T., Mayne L.V., van Zeeland A.A., Mullenders L.H., Venema J. Deficient repair of the transcribed strand of active genes in Cockayne's syndrome cells. Nucleic Acids Res. 1993, 21:5890-5895.
6. Hanawalt P.C., Spivak G. Transcription-coupled DNA repair: two decades of progress and surprises. Nat. Rev. Mol. Cell Biol. 2008, 9:958-970.
7. Lagerwerf S., Vrouwe M.G., Overmeer R.M., Fousteri M.I., Mullenders L.H. DNA damage response and transcription. DNA Repair (Amst.) 2011, 10:743-750.
8. Henning K.A., Li L., Iyer N., McDaniel L.D., Reagan M.S., Legerski R., Schultz R.A., Stefanini M., Lehmann A.R., Mayne L.V., Friedberg E.C. The Cockayne syndrome group A gene encodes a WD repeat protein that interacts with CSB protein and a subunit of RNA polymerase II TFIIH. Cell 1995, 82:555-564.
9. Troelstra C., van Gool A., de Wit J., Vermeulen W., Bootsma D., Hoeijmakers J.H. ERCC6, a member of a subfamily of putative helicases, is involved in Cockayne's syndrome and preferential repair of active genes. Cell 1992, 71:939-953.
10. Rass U., Ahel I., West S.C. Defective DNA repair and neurodegenerative disease. Cell 2007, 130:991-1004.
11. Itoh M., Hayashi M., Shioda K., Minagawa M., Isa F., Tamagawa K., Morimatsu Y., Oda M. Neurodegeneration in hereditary nucleotide repair disorders. Brain Dev. 1999, 21:326-333.
12. Brooks P.J., Cheng T.F., Cooper L. Do all of the neurologic diseases in patients with DNA repair gene mutations result from the accumulation of DNA damage?. DNA Repair (Amst.) 2008, 7:834-848.
13. van Gool A.J., van der Horst G.T., Citterio E., Hoeijmakers J.H. Cockayne syndrome: defective repair of transcription?. EMBO J. 1997, 16:4155-4162.
14. Bootsma D., Weeda G., Vermeulen W., van Vuuren H., Troelstra C., van der Spek P., Hoeijmakers J. Nucleotide excision repair syndromes: molecular basis and clinical symptoms. Philos. Trans. R: Soc. Lond. B: Biol. Sci. 1995, 347:75-81.
15. Hoeijmakers J.H., Egly J.M., Vermeulen W. TFIIH: a key component in multiple DNA transactions. Curr. Opin. Genet. Dev. 1996, 6:26-33.
16. Compe E., Egly J.M. TFIIH: when transcription met DNA repair. Nat. Rev. Mol. Cell Biol. 2012, 13:343-354.
17. Laugel V. Cockayne Syndrome 1993.
18. Pasquier L., Laugel V., Lazaro L., Dollfus H., Journel H., Edery P., Goldenberg A., Martin D., Heron D., Le Merrer M., Rustin P., Odent S., Munnich A., Sarasin A., Cormier-Daire V. Wide clinical variability among 13 new Cockayne syndrome cases confirmed by biochemical assays. Arch. Dis. Child. 2006, 91:178-182.
19. Kraemer K.H., Patronas N.J., Schiffmann R., Brooks B.P., Tamura D., DiGiovanna J.J. Xeroderma pigmentosum, trichothiodystrophy and Cockayne syndrome: a complex genotype-phenotype relationship. Neuroscience 2007, 145:1388-1396.
20. Weidenheim K.M., Dickson D.W., Rapin I. Neuropathology of Cockayne syndrome: evidence for impaired development, premature aging, and neurodegeneration. Mech. Ageing Dev. 2009, 130:619-636.
21. Nance M.A., Berry S.A. Cockayne syndrome: review of 140 cases. Am. J. Med. Genet. 1992, 42:68-84.
22. Natale V. A comprehensive description of the severity groups in Cockayne syndrome. Am. J. Med. Genet. A 2011, 155:1081-1095.
23. Rapin I., Weidenheim K., Lindenbaum Y., Rosenbaum P., Merchant S.N., Krishna S., Dickson D.W. Cockayne syndrome in adults: review with clinical and pathologic study of a new case. J. Child Neurol. 2006, 21:991-1006.
24. Lindenbaum Y., Dickson D., Rosenbaum P., Kraemer K., Robbins I., Rapin I. Xeroderma pigmentosum/cockayne syndrome complex: first neuropathological study and review of eight other cases. Eur. J. Paediatr. Neurol. 2001, 5:225-242.
25. Koob M., Laugel V., Durand M., Fothergill H., Dalloz C., Sauvanaud F., Dollfus H., Namer I.J., Dietemann J.L. Neuroimaging in Cockayne syndrome. Am. J. Neuroradiol. 2010, 31:1623-1630.
26. Hayashi M., Miwa-Saito N., Tanuma N., Kubota M. Brain vascular changes in Cockayne syndrome. Neuropathology 2012, 32:113-117.
27. Brumback R.A., Brooks P., Leech R. Cockayne syndrome. Pathology and Genetics: Developmental Neuropathology 2004, 318-323. ISN Neuropathology Press, Basel. G. JA, B. Harding (Eds.).
28. Scharer O.D. Multistep damage recognition, pathway coordination and connections to transcription, damage signaling, chromatin structure, cancer and aging: current perspectives on the nucleotide excision repair pathway. DNA Repair (Amst.) 2011, 10:667.
29. Friedberg E., Walker G., Siede W., Wood R., Schultz R., Ellenburger T. DNA Repair and Mutagenesis 2006, ASM Press, Washington, DC. 2nd ed.
30. Wood R.D., Robins P., Lindahl T. Complementation of the xeroderma pigmentosum DNA repair defect in cell-free extracts. Cell 1988, 53:97-106.
31. Mu D., Park C.H., Matsunaga T., Hsu D.S., Reardon J.T., Sancar A. Reconstitution of human DNA repair excision nuclease in a highly defined system. J. Biol. Chem. 1995, 270:2415-2418.
32. Riedl T., Hanaoka F., Egly J.M. The comings and goings of nucleotide excision repair factors on damaged DNA. EMBO J. 2003, 22:5293-5303.
33. Bohr V.A., Smith C.A., Okumoto D.S., Hanawalt P.C. DNA repair in an active gene: removal of pyrimidine dimers from the DHFR gene of CHO cells is much more efficient than in the genome overall. Cell 1985, 40:359-369.
34. Mellon I., Spivak G., Hanawalt P.C. Selective removal of transcription-blocking DNA damage from the transcribed strand of the mammalian DHFR gene. Cell 1987, 51:241-249.
35. Fousteri M., Mullenders L.H. Transcription-coupled nucleotide excision repair in mammalian cells: molecular mechanisms and biological effects. Cell Res. 2008, 18:73-84.
36. Diderich K., Alanazi M., Hoeijmakers J.H. Premature aging and cancer in nucleotide excision repair-disorders. DNA Repair (Amst.) 2011, 10:772-780.
37. Fousteri M., Vermeulen W., van Zeeland A.A., Mullenders L.H. Cockayne syndrome A and B proteins differentially regulate recruitment of chromatin remodeling and repair factors to stalled RNA polymerase II in vivo. Mol. Cell 2006, 23:471-482.
38. Fuss J.O., Tainer J.A. XPB and XPD helicases in TFIIH orchestrate DNA duplex opening and damage verification to coordinate repair with transcription and cell cycle via CAK kinase. DNA Repair (Amst.) 2011, 10:697-713.
39. Egly J.M., Coin F. A history of TFIIH: two decades of molecular biology on a pivotal transcription/repair factor. DNA Repair (Amst.) 2011, 10:714-721.
40. Fagbemi A.F., Orelli B., Scharer O.D. Regulation of endonuclease activity in human nucleotide excision repair. DNA Repair (Amst.) 2011, 10:722-729.
41. Lehmann A.R. DNA polymerases and repair synthesis in NER in human cells. DNA Repair (Amst.) 2011, 10:730-733.
42. Naegeli H., Sugasawa K. The xeroderma pigmentosum pathway: decision tree analysis of DNA quality. DNA Repair (Amst.) 2011, 10:673-683.
43. Hoeijmakers J.H. DNA damage, aging, and cancer. N. Engl. J. Med. 2009, 361:1475-1485.
44. van den Boom V., Citterio E., Hoogstraten D., Zotter A., Egly J.M., van Cappellen W.A., Hoeijmakers J.H., Houtsmuller A.B., Vermeulen W. DNA damage stabilizes interaction of CSB with the transcription elongation machinery. J. Cell Biol. 2004, 166:27-36.
45. Feng Z., Hu W., Komissarova E., Pao A., Hung M.C., Adair G.M., Tang M.S. Transcription-coupled DNA repair is genomic context-dependent. J. Biol. Chem. 2002, 277:12777-12783.
46. Nouspikel T., Hanawalt P.C. Terminally differentiated human neurons repair transcribed genes but display attenuated global DNA repair and modulation of repair gene expression. Mol. Cell. Biol. 2000, 20:1562-1570.
47. Nouspikel T.P., Hyka-Nouspikel N., Hanawalt P.C. Transcription domain-associated repair in human cells. Mol. Cell. Biol. 2006, 26:8722-8730.
48. Giglia-Mari G., Theil A.F., Mari P.O., Mourgues S., Nonnekens J., Andrieux L.O., de Wit J., Miquel C., Wijgers N., Maas A., Fousteri M., Hoeijmakers J.H., Vermeulen W. Differentiation driven changes in the dynamic organization of Basal transcription initiation. PLoS Biol. 2009, 7:e1000220.
49. Andrews A.D., Barrett S.F., Robbins J.H. Xeroderma pigmentosum neurological abnormalities correlate with colony-forming ability after ultraviolet radiation. Proc. Natl. Acad. Sci. U.S.A. 1978, 75:1984-1988.
50. Brooks P.J. The case for 8,5'-cyclopurine-2'-deoxynucleosides as endogenous DNA lesions that cause neurodegeneration in xeroderma pigmentosum. Neuroscience 2007, 145:1407-1417.
51. Przedborski S., Vila M., Jackson-Lewis V., Neurodegeneration What is it and where are we?. J. Clin. Invest. 2003, 111:3-10.
52. Robbins J.H., Brumback R.A., Mendiones M., Barrett S.F., Carl J.R., Cho S., Denckla M.B., Ganges M.B., Gerber L.H., Guthrie R.A., et al. Neurological disease in xeroderma pigmentosum. Documentation of a late onset type of the juvenile onset form. Brain 1991, 114(Pt 3):1335-1361.
53. Itoh T., Ono T., Yamaizumi M. A new UV-sensitive syndrome not belonging to any complementation groups of xeroderma pigmentosum or Cockayne syndrome: siblings showing biochemical characteristics of Cockayne syndrome without typical clinical manifestations. Mutat. Res. 1994, 314:233-248.
54. Nardo T., Oneda R., Spivak G., Vaz B., Mortier L., Thomas P., Orioli D., Laugel V., Stary A., Hanawalt P.C., Sarasin A., Stefanini M. A UV-sensitive syndrome patient with a specific CSA mutation reveals separable roles for CSA in response to UV and oxidative DNA damage. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:6209-6214.
55. Horibata K., Iwamoto Y., Kuraoka I., Jaspers N.G., Kurimasa A., Oshimura M., Ichihashi M., Tanaka K. Complete absence of Cockayne syndrome group B gene product gives rise to UV-sensitive syndrome but not Cockayne syndrome. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:15410-15415.
56. Zhang X., Horibata K., Saijo M., Ishigami C., Ukai A., Kanno S., Tahara H., Neilan E.G., Honma M., Nohmi T., Yasui A., Tanaka K. Mutations in UVSSA cause UV-sensitive syndrome and destabilize ERCC6 in transcription-coupled DNA repair. Nat. Genet. 2012, 44:593-597.
57. Schwertman P., Lagarou A., Dekkers D.H., Raams A., van der Hoek A.C., Laffeber C., Hoeijmakers J.H., Demmers J.A., Fousteri M., Vermeulen W., Marteijn J.A. UV-sensitive syndrome protein UVSSA recruits USP7 to regulate transcription-coupled repair. Nat. Genet. 2012, 44:598-602.
58. Nakazawa Y., Sasaki K., Mitsutake N., Matsuse M., Shimada M., Nardo T., Takahashi Y., Ohyama K., Ito K., Mishima H., Nomura M., Kinoshita A., Ono S., Takenaka K., Masuyama R., Kudo T., Slor H., Utani A., Tateishi S., Yamashita S., Stefanini M., Lehmann A.R., Yoshiura K., Ogi T. Mutations in UVSSA cause UV-sensitive syndrome and impair RNA polymerase IIo processing in transcription-coupled nucleotide-excision repair. Nat. Genet. 2012, 44:586-592.
59. Hashimoto S., Suga T., Kudo E., Ihn H., Uchino M., Tateishi S. Adult-onset neurological degeneration in a patient with Cockayne syndrome and a null mutation in the CSB gene. J. Invest. Dermatol. 2008, 128:1597-1599.
60. Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R., Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 2007, 316:1160-1166.
61. Stokes M.P., Rush J., Macneill J., Ren J.M., Sprott K., Nardone J., Yang V., Beausoleil S.A., Gygi S.P., Livingstone M., Zhang H., Polakiewicz R.D., Comb M.J. Profiling of UV-induced ATM/ATR signaling pathways. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:19855-19860.
62. Brooks P.J., Wise D.S., Berry D.A., Kosmoski J.V., Smerdon M.J., Somers R.L., Mackie H., Spoonde A.Y., Ackerman E.J., Coleman K., Tarone R.E., Robbins J.H. The oxidative DNA lesion 8,5'-(S)-cyclo-2'-deoxyadenosine is repaired by the nucleotide excision repair pathway and blocks gene expression in mammalian cells. J. Biol. Chem. 2000, 275:22355-22362.
63. Kuraoka I., Robins P., Masutani C., Hanaoka F., Gasparutto D., Cadet J., Wood R.D., Lindahl T. Oxygen free radical damage to DNA. Translesion synthesis by human DNA polymerase eta and resistance to exonuclease action at cyclopurine deoxynucleoside residues. J. Biol. Chem. 2001, 276:49283-49288.
64. Hong H., Cao H., Wang Y. Formation and genotoxicity of a guanine-cytosine intrastrand cross-link lesion in vivo. Nucleic Acids Res. 2007, 35:7118-7127.
65. Niedernhofer L.J., Daniels J.S., Rouzer C.A., Greene R.E., Marnett L.J. Malondialdehyde: a product of lipid peroxidation, is mutagenic in human cells. J. Biol. Chem. 2003, 278:31426-31433.
66. Cline S.D., Riggins J.N., Tornaletti S., Marnett L.J., Hanawalt P.C. Malondialdehyde adducts in DNA arrest transcription by T7 RNA polymerase and mammalian RNA polymerase II. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:7275-7280.
67. Jaruga P., Xiao Y., Nelson B.C., Dizdaroglu M. Measurement of (5'R)- and (5'S)-8,5'-cyclo-2'-deoxyadenosines in DNA in vivo by liquid chromatography/isotope-dilution tandem mass spectrometry. Biochem. Biophys. Res. Commun. 2009, 386:656-660.
68. Wang J., Yuan B., Guerrero C., Bahde R., Gupta S., Wang Y. Quantification of oxidative DNA lesions in tissues of Long-Evans Cinnamon rats by capillary high-performance liquid chromatography-tandem mass spectrometry coupled with stable isotope-dilution method. Anal. Chem. 2011, 83:2201-2209.
69. Wang J., Cao H., You C., Yuan B., Bahder R., Gupta S., Nishigori C., Niedernhofer L., Brooks P., Wang Y. Endogenous formation and repair of oxidatively induced G[8-5m]T intrastrand cross-link lesion. Nucleic Acids Res. 2012, 40:7368-7374.
70. Nair U., Bartsch H., Nair J. Lipid peroxidation-induced DNA damage in cancer-prone inflammatory diseases: a review of published adduct types and levels in humans. Free Radic. Biol. Med. 2007, 43:1109-1120.
71. Callegari A.J., Kelly T.J. UV irradiation induces a postreplication DNA damage checkpoint. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:15877-15882.
72. McKay B.C., Stubbert L.J., Fowler C.C., Smith J.M., Cardamore R.A., Spronck J.C. Regulation of ultraviolet light-induced gene expression by gene size. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:6582-6586.
73. Friedberg E.C. Retraction notice to "The yeast RAD2, but not RAD1, gene is involved in the transcription-coupled repair of thymine glycols" [Mutat. Res. 337 (1995) 169-178]. DNA Repair (Amst.) 2006, 5:1507.
74. Kim N., Jinks-Robertson S. Abasic sites in the transcribed strand of yeast DNA are removed by transcription-coupled nucleotide excision repair. Mol. Cell. Biol. 2010, 30:3206-3215.
75. Tornaletti S., Maeda L.S., Hanawalt P.C. Transcription arrest at an abasic site in the transcribed strand of template DNA. Chem. Res. Toxicol. 2006, 19:1215-1220.
76. Wang Y., Sheppard T.L., Tornaletti S., Maeda L.S., Hanawalt P.C. Transcriptional inhibition by an oxidized abasic site in DNA. Chem. Res. Toxicol. 2006, 19:234-241.
77. Reardon J.T., Bessho T., Kung H.C., Bolton P.H., Sancar A. In vitro repair of oxidative DNA damage by human nucleotide excision repair system: possible explanation for neurodegeneration in xeroderma pigmentosum patients. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:9463-9468.
78. Frosina G. The current evidence for defective repair of oxidatively damaged DNA in Cockayne syndrome. Free Radic. Biol. Med. 2007, 43:165-177.
79. Berquist B.R., Wilson D.M. Pathways for repairing and tolerating the spectrum of oxidative DNA lesions. Cancer Lett. 2012, 327:61-72.
80. Martin G.M. Genetic modulation of senescent phenotypes in Homo sapiens. Cell 2005, 120:523-532.
81. Heron E., Hernigou A., Chatellier G., Fornes P., Emmerich J., Fiessinger J.N. Intracerebral calcification in systemic sclerosis. Stroke 1999, 30:2183-2185.
82. Midroni G., Willinsky R. Rapid postanoxic calcification of the basal ganglia. Neurology 1992, 42:2144-2146.
83. Perlman J.M., Argyle C. Lethal cytomegalovirus infection in preterm infants: clinical, radiological, and neuropathological findings. Ann. Neurol. 1992, 31:64-68.
84. Stephenson J.B. Aicardi-Goutieres syndrome (AGS). Eur. J. Paediatr. Neurol. 2008, 12:355-358.
85. Harman D. Aging: a theory based on free radical and radiation chemistry. J. Gerontol. 1956, 11:298-300.
86. Martin G.M. The biology of aging: 1985-2010 and beyond. FASEB J. 2011, 25:3756-3762.
87. Hekimi S., Lapointe J., Wen Y. Taking a "good" look at free radicals in the aging process. Trends Cell Biol. 2011, 21:569-576.
88. D'Autreaux B., Toledano M.B. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat. Rev. Mol. Cell Biol. 2007, 8:813-824.
89. Le Belle J.E., Orozco N.M., Paucar A.A., Saxe J.P., Mottahedeh J., Pyle A.D., Wu H., Kornblum H.I. Proliferative neural stem cells have high endogenous ROS levels that regulate self-renewal and neurogenesis in a PI3K/Akt-dependant manner. Cell Stem Cell 2011, 8:59-71.
90. de Waard H., de Wit J., Andressoo J.O., van Oostrom C.T., Riis B., Weimann A., Poulsen H.E., van Steeg H., Hoeijmakers J.H., van der Horst G.T. Different effects of CSA and CSB deficiency on sensitivity to oxidative DNA damage. Mol. Cell. Biol. 2004, 24:7941-7948.
91. Kyng K.J., May A., Brosh R.M., Cheng W.H., Chen C., Becker K.G., Bohr V.A. The transcriptional response after oxidative stress is defective in Cockayne syndrome group B cells. Oncogene 2003, 22:1135-1149.
92. Newman J.C., Bailey A.D., Weiner A.M. Cockayne syndrome group B protein (CSB) plays a general role in chromatin maintenance and remodeling. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:9613-9618.
93. Wong H.K., Muftuoglu M., Beck G., Imam S.Z., Bohr V.A., Wilson D.M. Cockayne syndrome B protein stimulates apurinic endonuclease 1 activity and protects against agents that introduce base excision repair intermediates. Nucleic Acids Res. 2007, 35:4103-4113.
94. Filippi S., Latini P., Frontini M., Palitti F., Egly J.M., Proietti-De-Santis L. CSB protein is (a direct target of HIF-1 and) a critical mediator of the hypoxic response. EMBO J. 2008, 27:2545-2556.
95. Spivak G., Hanawalt P.C. Host cell reactivation of plasmids containing oxidative DNA lesions is defective in Cockayne syndrome but normal in UV-sensitive syndrome fibroblasts. DNA Repair (Amst.) 2006, 5:13-22.
96. Khobta A., Lingg T., Schulz I., Warken D., Kitsera N., Epe B. Mouse CSB protein is important for gene expression in the presence of a single-strand break in the non-transcribed DNA strand. DNA Repair (Amst.) 2010, 9:985-993.
97. Kamenisch Y., Fousteri M., Knoch J., von Thaler A.K., Fehrenbacher B., Kato H., Becker T., Dolle M.E., Kuiper R., Majora M., Schaller M., van der Horst G.T., van Steeg H., Rocken M., Rapaport D., Krutmann J., Mullenders L.H., Berneburg M. Proteins of nucleotide and base excision repair pathways interact in mitochondria to protect from loss of subcutaneous fat, a hallmark of aging. J. Exp. Med. 2010, 207:379-390.
98. Aamann M.D., Sorensen M.M., Hvitby C., Berquist B.R., Muftuoglu M., Tian J., de Souza-Pinto N.C., Scheibye-Knudsen M., Wilson D.M., Stevnsner T., Bohr V.A. Cockayne syndrome group B protein promotes mitochondrial DNA stability by supporting the DNA repair association with the mitochondrial membrane. FASEB J. 2010, 24:2334-2346.
99. Berquist B.R., Canugovi C., Sykora P., Wilson D.M., Bohr V.A. Human Cockayne syndrome B protein reciprocally communicates with mitochondrial proteins and promotes transcriptional elongation. Nucleic Acids Res. 2012, 40:8392-8405.
100. Scheibye-Knudsen M., Ramamoorthy M., Sykora P., Maynard S., Lin P.C., Minor R.K., Wilson Iii D.M., Cooper M., Spencer R., de Cabo R., Croteau D.L., Bohr V.A. Cockayne syndrome group B protein prevents the accumulation of damaged mitochondria by promoting mitochondrial autophagy. J. Exp. Med. 2012, 209:855-869.
101. Pascucci B., Lemma T., Iorio E., Giovannini S., Vaz B., Iavarone I., Calcagnile A., Narciso L., Degan P., Podo F., Roginskya V., Janjic B.M., Van Houten B., Stefanini M., Dogliotti E., D'Errico M. An altered redox balance mediates the hypersensitivity of Cockayne syndrome primary fibroblasts to oxidative stress. Aging Cell 2012, 11:520-529.
102. Schaeffer L., Roy R., Humbert S., Moncollin V., Vermeulen W., Hoeijmakers J.H., Chambon P., Egly J.M. DNA repair helicase: a component of BTF2 (TFIIH) basic transcription factor. Science 1993, 260:58-63.
103. Drapkin R., Reardon J.T., Ansari A., Huang J.C., Zawel L., Ahn K., Sancar A., Reinberg D. Dual role of TFIIH in DNA excision repair and in transcription by RNA polymerase II. Nature 1994, 368:769-772.
104. de Boer J., de Wit J., van Steeg H., Berg R.J., Morreau H., Visser P., Lehmann A.R., Duran M., Hoeijmakers J.H., Weeda G. A mouse model for the basal transcription/DNA repair syndrome trichothiodystrophy. Mol. Cell 1998, 1:981-990.
105. Faghri S., Tamura D., Kraemer K.H., Digiovanna J.J. Trichothiodystrophy: a systematic review of 112 published cases characterises a wide spectrum of clinical manifestations. J. Med. Genet. 2008, 45:609-621.
106. Liu J., Akoulitchev S., Weber A., Ge H., Chuikov S., Libutti D., Wang X.W., Conaway J.W., Harris C.C., Conaway R.C., Reinberg D., Levens D. Defective interplay of activators and repressors with TFIH in xeroderma pigmentosum. Cell 2001, 104:353-363.
107. Rochette-Egly C., Adam S., Rossignol M., Egly J.M., Chambon P. Stimulation of RAR alpha activation function AF-1 through binding to the general transcription factor TFIIH and phosphorylation by CDK7. Cell 1997, 90:97-107.
108. Rossignol M., Kolb-Cheynel I., Egly J.M. Substrate specificity of the cdk-activating kinase (CAK) is altered upon association with TFIIH. EMBO J. 1997, 16:1628-1637.
109. Takagi Y., Masuda C.A., Chang W.H., Komori H., Wang D., Hunter T., Joazeiro C.A., Kornberg R.D. Ubiquitin ligase activity of TFIIH and the transcriptional response to DNA damage. Mol. Cell 2005, 18:237-243.
110. Chymkowitch P., Le May N., Charneau P., Compe E., Egly J.M. The phosphorylation of the androgen receptor by TFIIH directs the ubiquitin/proteasome process. EMBO J. 2011, 30:468-479.
111. Lehmann A.R. The xeroderma pigmentosum group D (XPD) gene: one gene, two functions, three diseases. Genes Dev. 2001, 15:15-23.
112. Bergmann E., Egly J.M. Trichothiodystrophy, a transcription syndrome. Trends Genet. 2001, 17:279-286.
113. Orioli D., Compe E., Nardo T., Mura M., Giraudon C., Botta E., Arrigoni L., Peverali F.A., Egly J.M., Stefanini M. XPD mutations in trichothiodystrophy hamper collagen VI expression and reveal a role of TFIIH in transcription derepression. Hum. Mol. Genet. 2013, 22:1061-1073.
114. Compe E., Malerba M., Soler L., Marescaux J., Borrelli E., Egly J.M. Neurological defects in trichothiodystrophy reveal a coactivator function of TFIIH. Nat. Neurosci. 2007, 10:1414-1422.
115. Clarkson S.G. The XPG story. Biochimie 2003, 85:1113-1121.
116. Lee S.K., Yu S.L., Prakash L., Prakash S. Requirement of yeast RAD2, a homolog of human XPG gene, for efficient RNA polymerase II transcription: implications for Cockayne syndrome. Cell 2002, 109:823-834.
117. Ito S., Kuraoka I., Chymkowitch P., Compe E., Takedachi A., Ishigami C., Coin F., Egly J.M., Tanaka K. XPG stabilizes TFIIH, allowing transactivation of nuclear receptors: implications for Cockayne syndrome in XP-G/CS patients. Mol. Cell 2007, 26:231-243.
118. Friedberg E.C., Wood R.D. New insights into the combined Cockayne/xeroderma pigmentosum complex: human XPG protein can function in transcription factor stability. Mol. Cell 2007, 26:162-164.
119. Proietti-De-Santis L., Drane P., Egly J.M. Cockayne syndrome B protein regulates the transcriptional program after UV irradiation. EMBO J. 2006, 25:1915-1923.
120. Lake R.J., Geyko A., Hemashettar G., Zhao Y., Fan H.Y. UV-induced association of the CSB remodeling protein with chromatin requires ATP-dependent relief of N-terminal autorepression. Mol. Cell 2010, 37:235-246.
121. Lake R.J., Basheer A., Fan H.Y. Reciprocally regulated chromatin association of Cockayne syndrome protein B and p53 protein. J. Biol. Chem. 2011, 286:34951-34958.
122. Velez-Cruz R., Zadorin A.S., Coin F., Egly J.M. Sirt1 suppresses RNA synthesis after UV irradiation in combined xeroderma pigmentosum group D/Cockayne syndrome (XP-D/CS) cells. Proc. Natl. Acad. Sci. U.S.A. 2012, 110:E212-E220.
123. Frontini M., Proietti-De-Santis L. Interaction between the Cockayne syndrome B and p53 proteins: implications for aging. Aging (Albany, NY) 2012, 4:89-97.
124. Newman J.C., Bailey A.D., Fan H.Y., Pavelitz T., Weiner A.M. An abundant evolutionarily conserved CSB-PiggyBac fusion protein expressed in Cockayne syndrome. PLoS Genet. 2008, 4:e1000031.
125. Bailey A.D., Gray L.T., Pavelitz T., Newman J.C., Horibata K., Tanaka K., Weiner A.M. The conserved Cockayne syndrome B-piggyBac fusion protein (CSB-PGBD3) affects DNA repair and induces both interferon-like and innate antiviral responses in CSB-null cells. DNA Repair (Amst.) 2012, 11:488-501.
126. Bradsher J., Auriol J., Proietti de Santis L., Iben S., Vonesch J.L., Grummt I., Egly J.M. CSB is a component of RNA pol I transcription. Mol. Cell 2002, 10:819-829.
127. Iben S., Tschochner H., Bier M., Hoogstraten D., Hozak P., Egly J.M., Grummt I. TFIIH plays an essential role in RNA polymerase I transcription. Cell 2002, 109:297-306.
128. Lebedev A., Scharffetter-Kochanek K., Iben S. Truncated Cockayne syndrome B protein represses elongation by RNA polymerase I. J. Mol. Biol. 2008, 382:266-274.
129. Assfalg R., Lebedev A., Gonzalez O.G., Schelling A., Koch S., Iben S. TFIIH is an elongation factor of RNA polymerase I. Nucleic Acids Res. 2012, 40:650-659.
130. Yuan X., Feng W., Imhof A., Grummt I., Zhou Y. Activation of RNA polymerase I transcription by cockayne syndrome group B protein and histone methyltransferase G9a. Mol. Cell 2007, 27:585-595.
131. Xie W., Ling T., Zhou Y., Feng W., Zhu Q., Stunnenberg H.G., Grummt I., Tao W. The chromatin remodeling complex NuRD establishes the poised state of rRNA genes characterized by bivalent histone modifications and altered nucleosome positions. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:8161-8166.
132. Hoogstraten D., Nigg A.L., Heath H., Mullenders L.H., van Driel R., Hoeijmakers J.H., Vermeulen W., Houtsmuller A.B. Rapid switching of TFIIH between RNA polymerase I and II transcription and DNA repair in vivo. Mol. Cell 2002, 10:1163-1174.
133. Mayne L.V., Lehmann A.R. Failure of RNA synthesis to recover after UV irradiation: an early defect in cells from individuals with Cockayne's syndrome and xeroderma pigmentosum. Cancer Res. 1982, 42:1473-1478.
134. Rockx D.A., Mason R., van Hoffen A., Barton M.C., Citterio E., Bregman D.B., van Zeeland A.A., Vrieling H., Mullenders L.H. UV-induced inhibition of transcription involves repression of transcription initiation and phosphorylation of RNA polymerase II. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:10503-10508.
135. Hasegawa M., Iwai S., Kuraoka I. A non-isotopic assay uses bromouridine and RNA synthesis to detect DNA damage responses. Mutat. Res. 2010, 699:62-66.
136. Groisman R., Polanowska J., Kuraoka I., Sawada J., Saijo M., Drapkin R., Kisselev A.F., Tanaka K., Nakatani Y. The ubiquitin ligase activity in the DDB2 and CSA complexes is differentially regulated by the COP9 signalosome in response to DNA damage. Cell 2003, 113:357-367.
137. Hammond-Martel I., Yu H., Affar el B. Roles of ubiquitin signaling in transcription regulation. Cell. Signal. 2012, 24:410-421.
138. Fatyol K., Grummt I., Proteasomal ATPases are associated with rDNA: the ubiquitin proteasome system plays a direct role in RNA polymerase I transcription. Biochim. Biophys. Acta 2008, 1779:850-859.
139. Fischer E.S., Scrima A., Bohm K., Matsumoto S., Lingaraju G.M., Faty M., Yasuda T., Cavadini S., Wakasugi M., Hanaoka F., Iwai S., Gut H., Sugasawa K., Thoma N.H. The molecular basis of CRL4DDB2/CSA ubiquitin ligase architecture, targeting, and activation. Cell 2011, 147:1024-1039.
140. Moss T. At the crossroads of growth control; making ribosomal RNA. Curr. Opin. Genet. Dev. 2004, 14:210-217.
141. Jorgensen P., Rupes I., Sharom J.R., Schneper L., Broach J.R., Tyers M. A dynamic transcriptional network communicates growth potential to ribosome synthesis and critical cell size. Genes Dev. 2004, 18:2491-2505.
142. Shiratori M., Suzuki T., Itoh C., Goto M., Furuichi Y., Matsumoto T. WRN helicase accelerates the transcription of ribosomal RNA as a component of an RNA polymerase I-associated complex. Oncogene 2002, 21:2447-2454.
143. Grierson P.M., Lillard K., Behbehani G.K., Combs K.A., Bhattacharyya S., Acharya S., Groden J. BLM helicase facilitates RNA polymerase I-mediated ribosomal RNA transcription. Hum. Mol. Genet. 2012, 21:1172-1183.
144. Balajee A.S., Machwe A., May A., Gray M.D., Oshima J., Martin G.M., Nehlin J.O., Brosh R., Orren D.K., Bohr V.A. The Werner syndrome protein is involved in RNA polymerase II transcription. Mol. Biol. Cell 1999, 10:2655-2668.
145. Hetman M., Pietrzak M. Emerging roles of the neuronal nucleolus. Trends Neurosci. 2012, 35:305-314.
146. Parlato R., Kreiner G., Erdmann G., Rieker C., Stotz S., Savenkova E., Berger S., Grummt I., Schutz G. Activation of an endogenous suicide response after perturbation of rRNA synthesis leads to neurodegeneration in mice. J. Neurosci. 2008, 28:12759-12764.
147. Gorodetsky E., Calkins S., Ahn J., Brooks P.J. ATM, the Mre11/Rad50/Nbs1 complex, and topoisomerase I are concentrated in the nucleus of Purkinje neurons in the juvenile human brain. DNA Repair (Amst.) 2007, 6:1698-1707.
148. Boulon S., Westman B.J., Hutten S., Boisvert F.M., Lamond A.I. The nucleolus under stress. Mol. Cell 2010, 40:216-227.
149. Laposa R.R., Huang E.J., Cleaver J.E. Increased apoptosis, p53 up-regulation, and cerebellar neuronal degeneration in repair-deficient Cockayne syndrome mice. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:1389-1394.
150. Jaarsma D., van der Pluijm I., de Waard M.C., Haasdijk E.D., Brandt R., Vermeij M., Rijksen Y., Maas A., van Steeg H., Hoeijmakers J.H., van der Horst G.T. Age-related neuronal degeneration: complementary roles of nucleotide excision repair and transcription-coupled repair in preventing neuropathology. PLoS Genet. 2011, 7:e1002405.
151. Vaurs-Barriere C., Deville M., Sarret C., Giraud G., Des Portes V., Prats-Vinas J.M., De Michele G., Dan B., Brady A.F., Boespflug-Tanguy O., Touraine R. Pelizaeus-Merzbacher-like disease presentation of MCT8 mutated male subjects. Ann. Neurol. 2009, 65:114-118.
152. Rodriguez-Pena A. Oligodendrocyte development and thyroid hormone. J. Neurobiol. 1999, 40:497-512.
153. McTigue D.M., Tripathi R.B. The life, death, and replacement of oligodendrocytes in the adult CNS. J. Neurochem. 2008, 107:1-19.
154. Nakahira K., Haspel J.A., Rathinam V.A., Lee S.J., Dolinay T., Lam H.C., Englert J.A., Rabinovitch M., Cernadas M., Kim H.P., Fitzgerald K.A., Ryter S.W., Choi A.M. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat. Immunol. 2011, 12:222-230.
155. van der Horst G.T., van Steeg H., Berg R.J., van Gool A.J., de Wit J., Weeda G., Morreau H., Beems R.B., van Kreijl C.F., de Gruijl F.R., Bootsma D., Hoeijmakers J.H. Defective transcription-coupled repair in Cockayne syndrome B mice is associated with skin cancer predisposition. Cell 1997, 89:425-435.
156. van der Horst G.T., Meira L., Gorgels T.G., de Wit J., Velasco-Miguel S., Richardson J.A., Kamp Y., Vreeswijk M.P., Smit B., Bootsma D., Hoeijmakers J.H., Friedberg E.C. UVB radiation-induced cancer predisposition in Cockayne syndrome group A (Csa) mutant mice. DNA Repair (Amst.) 2002, 1:143-157.
157. Revet I., Feeney L., Tang A.A., Huang E.J., Cleaver J.E. Dysmyelination not demyelination causes neurological symptoms in preweaned mice in a murine model of Cockayne syndrome. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:4627-4632.
158. Murai M., Enokido Y., Inamura N., Yoshino M., Nakatsu Y., van der Horst G.T., Hoeijmakers J.H., Tanaka K., Hatanaka H. Early postnatal ataxia and abnormal cerebellar development in mice lacking 1Xeroderma pigmentosum Group A and Cockayne syndrome Group B DNA repair genes. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:13379-13384.
159. Gorgels T.G., van der Pluijm I., Brandt R.M., Garinis G.A., van Steeg H., van den Aardweg G., Jansen G.H., Ruijter J.M., Bergen A.A., van Norren D., Hoeijmakers J.H., van der Horst G.T. Retinal degeneration and ionizing radiation hypersensitivity in a mouse model for Cockayne syndrome. Mol. Cell. Biol. 2007, 27:1433-1441.
160. Clarke G., Collins R.A., Leavitt B.R., Andrews D.F., Hayden M.R., Lumsden C.J., McInnes R.R. A one-hit model of cell death in inherited neuronal degenerations. Nature 2000, 406:195-199.
161. Clarke G., Lumsden C.J., McInnes R.R. Inherited neurodegenerative diseases: the one-hit model of neurodegeneration. Hum. Mol. Genet. 2001, 10:2269-2275.
162. Neilan E.G., Delgado M.R., Donovan M.A., Kim S.Y., Jou R.L., Wu B.L., Kang P.B. Response of motor complications in Cockayne syndrome to carbidopa-levodopa. Arch. Neurol. 2008, 65:1117-1121.
163. Fox J.T., Sakamuru S., Huang R., Teneva N., Simmons S.O., Xia M., Tice R.R., Austin C.P., Myung K. High-throughput genotoxicity assay identifies antioxidants as inducers of DNA damage response and cell death. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:5423-5428.
164. Frantz M.C., Wipf P. Mitochondria as a target in treatment. Environ. Mol. Mutagen. 2010, 51:462-475.
165. Gray L.T., Fong K.K., Pavelitz T., Weiner A.M. Tethering of the conserved piggyBac transposase fusion protein CSB-PGBD3 to chromosomal AP-1 proteins regulates expression of nearby genes in humans. PLoS Genet. 2012, 8:e1002972.
166. Anindya R., Mari P.O., Kristensen U., Kool H., Giglia-Mari G., Mullenders L.H., Fousteri M., Vermeulen W., Egly J.M., Svejstrup J.Q. A ubiquitin-binding domain in Cockayne syndrome B required for transcription-coupled nucleotide excision repair. Mol. Cell 2010, 38:637-648.